World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 14 July 2014
Main ID:  ISRCTN71577271
Date of registration: 19/10/2005
Primary sponsor: University of Aberdeen (UK)
Public title: Development, implementation and evaluation of an integrated follow-up programme for people with cutaneous malignant melanoma N/A
Scientific title:
Date of first enrolment: Apr 1 2005
Target sample size: 150
Recruitment status: Completed/Not recruiting
URL:  http://isrctn.org/ISRCTN71577271
Study type:  Interventional
Study design:  Randomised controlled trial  
Countries of recruitment
Contacts
Key inclusion & exclusion criteria
Inclusion criteria: People previously treated for cutaneous malignant melanoma.
Exclusion criteria: 1. Non cutaneous melanoma
2. Active recurrence or a recurrence within the last 12 months
3. Terminally ill
4. Mentally ill
5. If their general practitioner believes them to be otherwise unsuitable for participation in the study


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Cutaneous Malignant Melanoma
Intervention(s)
Integrated primary care based follow-up programme for cutaneous malignant melanoma. Intervention comprises general practitioner training, central appointments database, patient education programme, protocol driven reviews in primary care, rapid access pathway to secondary care.

The control group continue to attend follow-up at the Joint Melanoma Clinic, Aberdeen Royal Infirmary. This would be termed 'usual care' as it is the current standard treatment for people treated for melanoma.
Primary Outcome(s)
Patient satisfaction and adherence to guidelines
Secondary Outcome(s)
1. Psychological and physical well-being
2. Costs to patients and health services
3. Processes of care
Secondary ID(s)
C10673/A3912
Source(s) of Monetary Support
Cancer Research UK (CRUK) (UK) (ref: C10673/A3912)
Secondary Sponsor(s)
N/A
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history